EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ECPELLA as a bridge-to-decision in refractory cardiogenic shock: a single-centre experience

Jan-Willem Balder, Mariusz K Szymanski, Linda W van Laake, Pim van der Harst, Christiaan L Meuwese, Faiz Z Ramjankhan, Manon G van der Meer, Jeannine A J M Hermens, Michiel Voskuil, Eric E C de Waal, Dirk W Donker, Marish I F J Oerlemans und 1 weitere

Netherlands Heart Journal · 2024-06 · 32 (6) · 245-253

DOI: 10.1007/s12471-024-01872-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Netherlands Heart Journal, online erschienen am 07.05.2024. Verfasst von Jan-Willem Balder und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands. j.balder@umcutrecht.nl. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In refractory cardiogenic shock, temporary mechanical support (tMCS) may be crucial for maintaining tissue perfusion and oxygen delivery. tMCS can serve as a bridge-to-decision to assess eligibility for left ventricular assist device (LVAD) implantation or heart transplantation, or as a bridge-to-recovery. ECPELLA is a novel tMCS configuration combining venoarterial extracorporeal membrane oxygenation with Impella. The present study presents the clinical parameters, outcomes, and complications of patients supported with ECPELLA.

Methods

All patients supported with ECPELLA at University Medical Centre Utrecht between December 2020 and August 2023 were included. The primary outcome was 30-day mortality, and secondary outcomes were LVAD implantation/heart transplantation and safety outcomes.

Results

Twenty patients with an average age of 51 years, and of whom 70% were males, were included. Causes of cardiogenic shock were acute heart failure (due to acute coronary syndrome, myocarditis, or after cardiac surgery) or chronic heart failure, respectively 70 and 30% of cases. The median duration of ECPELLA support was 164 h (interquartile range 98–210). In 50% of cases, a permanent LVAD was implanted. Cardiac recovery within 30 days was seen in 30% of cases and 30-day mortality rate was 20%. ECPELLA support was associated with major bleeding (40%), haemolysis (25%), vascular complications (30%), kidney failure requiring replacement therapy (50%), and Impella failure requiring extraction (15%).

Conclusion

ECPELLA can be successfully used as a bridge to LVAD implantation or as a bridge-to-recovery in patients with refractory cardiogenic shock. Despite a significant number of complications, 30-day mortality was lower than observed in previous cohorts.

Schlagwörter

Stichwörter der Autor:innen

Cardiogenic shockImpellaLeft ventricular assist deviceObservational studyVenoarterial extracorporeal membrane oxygenation

Autor:innen und Institutionen

  • Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands. j.balder@umcutrecht.nl.
  • Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Department of Cardiology, Erasmus Medical Centre, Rotterdam, The Netherlands.
  • Department of Intensive Care, Erasmus Medical Centre, Rotterdam, The Netherlands.
  • Department of Cardiothoracic Surgery, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Department of Intensive Care, University Medical Centre Utrecht, Utrecht, The Netherlands.

Zitieren

APA

Balder, J. W., Szymanski, M. K., van Laake, L. W., van der Harst, P., Meuwese, C. L., Ramjankhan, F. Z., van der Meer, M. G., Hermens, J. A. J. M., Voskuil, M., de Waal, E. E. C., Donker, D. W., Oerlemans, M. I. F. J., & Kraaijeveld, A. O. (2024). ECPELLA as a bridge-to-decision in refractory cardiogenic shock: a single-centre experience. Netherlands Heart Journal, 32(6), 245-253. https://doi.org/10.1007/s12471-024-01872-w

Vancouver

Balder JW, Szymanski MK, van Laake LW, van der Harst P, Meuwese CL, Ramjankhan FZ, et al. ECPELLA as a bridge-to-decision in refractory cardiogenic shock: a single-centre experience. Netherlands Heart Journal. 2024;32(6):245-253. doi:10.1007/s12471-024-01872-w

BibTeX
@article{Balder2024,
  author = {Balder, Jan-Willem and Szymanski, Mariusz K and van Laake, Linda W and van der Harst, Pim and Meuwese, Christiaan L and Ramjankhan, Faiz Z and van der Meer, Manon G and Hermens, Jeannine A J M and Voskuil, Michiel and de Waal, Eric E C and Donker, Dirk W and Oerlemans, Marish I F J and Kraaijeveld, Adriaan O},
  title = {ECPELLA as a bridge-to-decision in refractory cardiogenic shock: a single-centre experience},
  journal = {Netherlands Heart Journal},
  year = {2024},
  volume = {32},
  number = {6},
  pages = {245--253},
  doi = {10.1007/s12471-024-01872-w}
}
Kostenlos starten →